Showing results (141-150 of 246) with videos related to

Sort By:
Pageof 25
International Journal of Molecular Epidemiology and Genetics|November 8, 2014
Sex hormone pathway gene polymorphisms are associated with risk of advanced hepatitis C-related liver disease in malesDonna L White, Yanhong Liu, Jose Garcia, et al.
Anticancer Research|February 11, 2014
Activation of YAP1 is associated with poor prognosis and response to taxanes in ovarian cancerWoojin Jeong, Sang-Bae Kim, Bo Hwa Sohn, et al.
Carcinogenesis|May 15, 2012
FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repairYun-Yong Park, Sung Yun Jung, Nicholas B Jennings, et al.
Immunity|July 25, 2020
Anti-inflammatory Roles of Glucocorticoids Are Mediated by Foxp3+ Regulatory T Cells via a miR-342-Dependent MechanismDongkyun Kim, Quang Tam Nguyen, Juyeun Lee, et al.
Plos One|April 30, 2013
Comparison of prognostic genomic predictors in colorectal cancerYun-Yong Park, Sung Sook Lee, Jae Yun Lim, et al.
Scientific Reports|August 31, 2017
The Prognostic 97 Chemoresponse Gene Signature in Ovarian CancerAbel Matondo, Yong Hwa Jo, Muhammad Shahid, et al.
Carcinogenesis|July 4, 2014
Potentially functional variants in the core nucleotide excision repair genes predict survival in Japanese gastric cancer patientsYangkai Li, Zhensheng Liu, Hongliang Liu, et al.
Cells|April 1, 2020
A Regulatory Noncoding RNA, nc886, Suppresses Esophageal Cancer by Inhibiting the AKT Pathway and Cell Cycle ProgressionWonkyun Ronny Im, Hyun-Sung Lee, Yeon-Su Lee, et al.
Oncology|January 10, 2014
Reassessing hepatocellular carcinoma staging in a changing patient populationAhmed O Kaseb, Neeraj N Shah, Hesham M Hassabo, et al.
EMBO Molecular Medicine|December 17, 2011
Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancerYun-Yong Park, Kyounghyun Kim, Sang-Bae Kim, et al.
Pageof 25